Related Experiment Videos
Unusual locations of involvement by malignancies: Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh
Geetha N Varma1, Janet S Winston, Hank C Hill
1Roswell Park Cancer Institute, Buffalo, NY, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.
Cancer research communications·2026
Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
When Survival Separates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Transcriptomic Plasticity and Its Spatial Architecture Shape Melanoma Response to Immunotherapy and Its Combination With BRAF/MEKi.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
CAF-derived BHB modulates FXR1-Kbhb and NK-cell lipid metabolism in osteosarcoma.
International journal of biological sciences·2026